首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿替普酶静脉溶栓治疗发病3~4.5 h急性脑梗死的疗效及安全性研究
引用本文:尚俊英,李雪峰,赵虹,李亚楠,刘菊,袁烨.阿替普酶静脉溶栓治疗发病3~4.5 h急性脑梗死的疗效及安全性研究[J].国际病理科学与临床杂志,2016(12):1923-1927.
作者姓名:尚俊英  李雪峰  赵虹  李亚楠  刘菊  袁烨
作者单位:1. 首都医科大学石景山教学医院北京市石景山医院神内二病区,北京,100043;2. 北京市丰台中西医结合医院骨科,北京,100072
基金项目:北京市石景山医院基金(2014-05)。This work was supported by Shijingshan Hospital of Beijing Fund Project(2014-05),P. R. China
摘    要:目的:探讨阿替普酶(alteplase,rt-PA)静脉溶栓用于发病3~4.5 h急性脑梗死患者的临床疗效及安全性。方法:将152例发病在3~4.5 h的急性脑梗死患者随机分配至观察组(n=76)和对照组(n=76),对照组采用拜阿司匹林治疗,观察组在对照组的基础上给予r t-PA静脉溶栓。观察两组临床疗效及治疗期间的出血性转化率。结果:两组治疗前美国国立卫生研究院卒中量表(national institutes of health stroke scale,NIHSS)、Barthel指数(BI)评分比较,差异无统计学意义(P>0.05),治疗后14,30,90 d观察组的NIHSS评分低于对照组,BI评分高于对照组,差异均有显著统计学意义(P<0.01);治疗后90 d观察组的改良Rankin量表(mRS)评估结果显著优于对照组(P<0.01);观察组治疗期间的出血性转化率高于对照组,但两组比较差异无统计学意义(P>0.05)。结论:rt-PA静脉溶栓治疗在3~4.5 h急性脑梗死患者中仍具有显著效果,且并未明显增加出血性转化率。

关 键 词:急性脑梗死  阿替普酶  静脉溶栓

Clinical efficacy and safety of intravenous thrombolysis treated with alteplase on acute cerebral infarction within 3-4.5 h
Abstract:Objective: To investigate the clinical efficacy and safety of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute cerebral infarction (3—4.5 h).Methods: 152 patients with acute cerebral infarction (3—4.5 h) were randomly assigned to the observation group (n=76) and control group (n=76). hTe control group was given aspirin therapy, the observation group was given rt-PA intravenous thrombolysis on the basis of the control group. Observed the clinical curative effect of the two groups and the hemorrhagic transformation rate.Results: hTe difference of National Institutes of Health Stroke Scale (NIHSS) and Barthel index (BI) scores were not statistically significant (P>0.05) before treatment. The difference of NIHSS and BI scores (14th day, 30th day, 90th day atfer treatment) of two groups were statistically signiifcant (P<0.01); NIHSS was lower, the BI was higher compared to control group. hTe modiifed Rankin scale (mRS) (90th day) in the observation group was signiifcantly better than the control group (P<0.01). hTe hemorrhagic transformation rate of the observation group was higher than that of the control group, but there was no signiifcant difference between the two groups (P>0.05).Conclusion: rt-PA intravenous thrombolytic therapy in patients with acute cerebral infarction in 3—4.5 h still has signiifcantly effect, and does not signiifcantly increase the rate of hemorrhagic transformation.
Keywords:acute cerebral infarction  alteplase  intravenous thrombolysis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号